Sentences with phrase «annual reports on»

Students studying and creating annual reports on the total number of disciplinary actions that push students out of the classroom based on gender, race, economic status and abilities.

Accountability measures such as requiring charters to post meeting notices and minutes on their websites as well as the publishing of annual reports on charter school performance.

Sixteen states and the District of Columbia currently have established standards to which authorizers must adhere.32 33 Further, ECS finds that more states are requiring authorizers to submit annual reports on their portfolios of schools to ensure transparency for both operations and results.

They could eliminate the Title II provision (added in the Clinton era re-authorization, in 1998) for annual reports on how many teachers or administrators per education school pass licensure tests for working in a K - 12 school.

NEPC annual reports on Schoolhouse Commercialism have highlighted the intensifying surveillance culture and other dangers to student privacy in the digital age, and Facebook has emerged as a primary culprit.

SRI produced four annual reports on study design and preliminary findings.

As it stands now, not a single state publishes annual reports on the levels of income diversity and segregation within their schools and districts.

Tulane University's Cowen Institute issues annual reports on New Orleans school performance and its most recent edition examines progress over this period.

In the state's annual reports on test score gains, the researcher has repeatedly taken note of the lower average income for scholarship students.

Under the recommendation, the Education Department would require Middle States to submit annual reports on any actions taken against postsecondary institutions because of the diversity standard.

After all, the Arizona State shop promises that this is just the first of many annual reports on the impact of high - stakes testing.

Launching Ofsted's annual reports on December 10, Her Majesty's Chief Inspector Sir Michael Wilshaw has warned that the gap in performance between primary and secondary schools in England is widening.

NASA has just published «Spinoff 2013,» the latest of its annual reports on outstanding innovations developed for space that are solving problems and improving lives here on Earth.

In addition, AHRQ funds annual reports on the quality of U.S. health care, supports training of health services researchers, and works to disseminate research findings on best treatments.

ESHRE's own annual reports on fertility treatments in Europe show a rise in egg donation cycles from 15,028 in 2007 to 24,517 in 2010 (to 4.05 % of all treatments).

A revised bill, announced Sunday evening, will include a 15 - person advisory council and require annual reports on the Justice Center's activities.

Frank Mauro, Executive Director of the Fiscal Policy Institute discussed the relevance to this year's Congressional elections of Senator Daniel P. Moynihan's annual reports on New York State and the Federal Fisc.

The source of this data is the Tropical Commodity Coalition, a group of ten NGOs that puts out annual reports on various aspects of the coffee, tea, and cocoa industries.

The State Department's Office of International Religious Freedom (IRF)-- established nearly 20 years ago under the Clinton administration — is officially tasked with annual reports on the state of religious freedom around the world.

Most corporations are required to file annual reports on the financial status of the company.

Our annual Reports on Angel Investing Activity in Canada identify key statistics and trends in the visible Canadian Angel capital market as measured by the activity of Angel groups.

I used old annual reports on sedar.com to determine the streak.

The Social Security and Medicare Trustees today released their annual reports on the financial status of the two programs.

Because the CNGC already regularly analyzes whether our incentive compensation programs provide proper incentives to our NEOs to achieve our Company's strategic priorities (including ROI) and because our shareholders already receive annual reports on those matters in the CD&A s in our annual proxy statements, we believe the adoption of the policy requested by the proposal is unnecessary, duplicative of practices already followed by the CNGC and our Company, and would result in an expenditure of Walmart's resources and our management's and directors» time that ultimately would not be in our shareholders» best interests.

In preparing annual reports on the video surveillance market, Woodhouse has seen many moon - shot companies come and go.

Certain risk factors that may affect our business operations, financial condition and results of operations are included in our filings with the SEC, including our annual reports on Form 10 - K, quarterly reports on Form 10 - Q and current reports on Form 8 - K.

For a more complete discussion of these and other risk factors, please see each of McDermott's and CB&I's annual and quarterly filings with the U.S. Securities and Exchange Commission (the «SEC»), including their respective annual reports on Form 10 - K for the year ended December 31, 2017.

In our 17th annual report on the richest people in Canada, we celebrate both the upper - crust establishment figures who dominate the society pages and the self - starters who built their empires from scratch (and are busily dismantling the ones that came before).

Additional information concerning these and other factors can be found in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10 - K and Quarterly Reports on Form 10 - Q.

Actual results or outcomes may differ materially from those implied by the forward - looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10 - K and our other reports filed with the Securities and Exchange Commission.

Risk factors, cautionary statements and other conditions which could cause SkyWest's actual results to differ materially from management's current expectations are contained in SkyWest's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10 - K and Quarterly Reports on Form 10 - Q.

CNBC's Kayla Tausche reports on the U.S. Trade Representative's annual report on intellectual property violations.

For a glossary of other financial terms used in this press release, we refer you to the Company's most recent annual report on Form 10 - K filed with the SEC on February 15, 2018 and subsequent periodic filings with the SEC.

The change was announced alongside the release of Google's annual report on inappropriate ad trends.

This selected financial information should be read in conjunction with the consolidated financial statements and notes thereto included in Alkermes plc's Annual Report on Form 10 - Q for the three months ended March 31, 2018, which the company intends to file in April 2018.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

Information regarding the officers and directors of McDermott is included in its annual report on Form 10 - K for the year ended December 31, 2017, filed with the SEC on February 21, 2018, as amended by its annual report on Form 10 - K / A filed with the SEC on March 8, 2018.

Please also see the company's risk factors, as they may be amended from time to time, set forth in its filings with the SEC, including the company's most recently filed Annual Report on Form 10 - K.

The state government has announced a better - than - expected result in its annual report on state finances for 2014 - 15, but Treasurer Mike Nahan says Western Australia has a long way to go before it returns to surplus.

Further, PDC urges you to carefully review and consider the cautionary statements and disclosures, specifically those under the heading «Risk Factors,» made in its Quarterly Report on Form 10 - Q, its Annual Report on Form 10 - K for the year ended December 31, 2016 (the «2016 Form 10 - K»), filed with the U.S. Securities and Exchange Commission («SEC») on February 28, 2017 and amended on May 1, 2018, and other filings with the SEC for further information on risks and uncertainties that could affect the Company's business, financial condition, results of operations, and prospects, which are incorporated by this reference as though fully set forth herein.

Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.

Kleiner Perkins conducts an annual report on the digital landscape.

The company refers you to the documents filed by the company from time to time with the SEC, specifically the section titled «Risk Factors» in the company's Annual Report on Form 10 - K for the year ended December 31, 2017, as may be updated or supplemented in the company's Quarterly Reports on Form 10 - Q and the company's other filings with the SEC, which discuss these and other factors that could adversely affect the company's results.

Workers in Belgium, Germany, Austria and Hungary face the highest tax burdens, according to the OECD's annual report on individual income taxes.

The ECB's annual report on its work as the euro zone's top banking watchdog shows some banks were found to be deficient in the way they identify problem customers and loans, set aside provisions and choose when to grant credit, among other areas.

Since we're on the subject of health insurance, let's look at one other surprise that Kaiser delivered in its annual report on employer health benefits.

Actual results may differ materially from those indicated by these forward - looking statements as a result of various important factors including, but not limited to, the effects of any unexpected difficulty in closing our financial books for the quarter and other factors that are discussed in the Company's Annual Report on Form 10 - K, quarterly reports on Form 10 - Q, and other documents periodically filed with the SEC.

Forward - looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10 - K and any subsequent periodic reports on Form 10 - Q and Form 8 - K.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.

Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).